A Platform Approach to Manage the Automated Production of Viral Vectors for Cell and Gene Therapy
PEGS Europe, Barcelona, Spain
November 4, 2021
The efficient production of high quality viral vectors such as recombinant adeno associated virus (rAAV) and lentivirus represents a key step of any cell and gene therapy (CGT) discovery workflow. Here, we demonstrate how the Genedata Biologics® platform can be used for the registration of virus vectors as well as the monitoring, controlling and evaluation of production processes performed in the laboratory. The streamlined data management of such highly complex, automated and high throughput processes is key for process optimization and accelerated identification of therapeutic CGT candidates.